Global Disease Detection (GDD) Program Fact Sheet
People. Pathogens. Protection.
How We Do It
By building strong partnerships and scientific systems, the Global Disease Detection Program (GDD) protects the United States and countries around the world from health, safety, and security threats, both foreign and domestic.
GDD Centers have built laboratory diagnostic testing capacity in more than 500 laboratory facilities.
GDD Centers partner with host countries to develop surveillance for key diseases, integrating laboratory, clinical, and epidemiological information to:
- Guide interventions and other disease control measures
- Evaluate new laboratory diagnostics
- Provide data to improve health outcomes
- Limit the spread of disease
To create robust, sustainable health systems both nationally and across regions, CDC infectious disease experts based in GDD Centers share their expert knowledge with local public health professionals. In the last 11 years, our scientists have published more than 1000 scientific articles in peer-reviewed journals.
GDD works closely with a variety of in-country partners including ministries of health, academic institutions, other U.S. government programs, and international and nongovernmental organizations.
Responded to more than 2,200 disease outbreaks and other public health emergencies over the past 11 years
Advancing the Science to Stop Global Health Threats
The GDD Program was established in 2004 in response to the Severe Acute Respiratory Syndrome (SARS) epidemic to ensure deadly infectious diseases are detected and stopped before spreading to the United States and other countries. Since then, GDD has been at the scientific forefront of global health protection, from discovering new pathogens and building laboratory diagnostic testing capacity to offering technical support in emergencies. Long established, trusted relationships with country governments allow GDD Centers to prevent, detect, and rapidly respond to public health threats.